G01N 33/5754
Of the renal system
Official title: of the renal system, e.g. kidneys or ureters
G01N33/5754 (Of the renal system) appears on 14 US grants and 30 published applications in this corpus.
Search patents in G01N- Granted patents
- 14
- Published applications
- 30
- Assignees
- 26
- Inventors
- 90
- Latest grant
- 19 May 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1984 | 1 | 0 |
| 1985 | 0 | 0 |
| 1986 | 0 | 0 |
| 1987 | 0 | 0 |
| 1988 | 0 | 0 |
| 1989 | 0 | 0 |
| 1990 | 2 | 0 |
| 1991 | 0 | 0 |
| 1992 | 0 | 0 |
| 1993 | 0 | 0 |
| 1994 | 0 | 0 |
| 1995 | 0 | 0 |
| 1996 | 0 | 0 |
| 1997 | 0 | 0 |
| 1998 | 0 | 0 |
| 1999 | 0 | 0 |
| 2000 | 0 | 0 |
| 2001 | 0 | 0 |
| 2002 | 0 | 0 |
| 2003 | 0 | 0 |
| 2004 | 0 | 1 |
| 2005 | 0 | 2 |
| 2006 | 0 | 1 |
| 2007 | 0 | 0 |
| 2008 | 0 | 0 |
| 2009 | 1 | 1 |
| 2010 | 0 | 0 |
| 2011 | 0 | 0 |
| 2012 | 0 | 0 |
| 2013 | 0 | 2 |
| 2014 | 0 | 2 |
| 2015 | 0 | 2 |
| 2016 | 1 | 1 |
| 2017 | 1 | 2 |
| 2018 | 0 | 2 |
| 2019 | 0 | 1 |
| 2020 | 2 | 1 |
| 2021 | 1 | 3 |
| 2022 | 2 | 4 |
| 2023 | 0 | 2 |
| 2024 | 0 | 0 |
| 2025 | 2 | 1 |
| 2026 | 1 | 2 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Renal cancer detection method and test drug19 May 2026US 12,631,642 B2Public University Corporation Yokohama City University
- Keratin 17 as a biomarker for bladder cancer22 Jul 2025US 12,366,574 B2Kdx Diagnostics, Inc.
- Diagnostic tools and treatments for clear cell renal cell carcinoma22 Apr 2025US 12,281,362 B2University of Cincinnati
- Biomarkers of therapeutic responsiveness11 Oct 2022US 11,467,161 B2Meso Scale Technologies, LLC.
- Keratin 17 as a biomarker for bladder cancer14 Jun 2022US 11,360,092 B2Kdx Diagnostics, Inc.
- Bladder cancer detection proteins and methods of use thereof13 Aug 2026US 2026/0235607 A1Novelna Inc.
- Inflammatory disease gene panel9 Apr 2026US 2026/0098305 A1Ludwig Enterprises, Inc
- Extracellular vesicle biomarkers for bladder cancer19 Jun 2025US 2025/0199007 A1Tymora Analytical Operations, LLC
- Immune gene signatures in muscle invasive bladder cancer12 Oct 2023US 2023/0323468 A1H. Lee Moffitt Cancer Center and Research Institute, Inc.
- Method for judging risk of suffering kidney cancer20 Jul 2023US 2023/0228757 A1Chang Gung Memorial Hospital, Linkou
Most cited
By later US patents
- Methods for diagnosing RCC and other solid tumors30US 7,611,839 B2Wyeth · 2009
- Bladder cancer detection11US 4,447,545 ANew England Deaconess Hospital Corporation · 1984
- ELISA detection of urine DEK to predict and diagnose bladder cancer in humans7US 10,845,365 B2Medical Diagnostic Laboratories, LLC · 2020
- Method for characterizing types of renal carcinoma and prognosis3US 4,935,344 ASloan-Kettering Institute for Cancer Research · 1990
- Biomarkers of therapeutic responsiveness2US 11,467,161 B2Meso Scale Technologies, LLC. · 2022